Skip to main content
. Author manuscript; available in PMC: 2013 Jun 24.
Published in final edited form as: J Gastrointest Surg. 2012 Jan 13;16(3):460–468. doi: 10.1007/s11605-011-1798-x

Fig. 3.

Fig. 3

Pan02 cell migration when treated with the plasma fraction of stored pRBCs with or without gefitinib (G) was significantly decreased in cells exposed to “outdate,” D.42 NLR blood (*p<0.001). Treatment with gefitinib did not affect Pan02 migration in cells exposed to “outdate” D.42 LR or any D.1 blood. HPF high-powered field, DMEM Dulbecco’s minimal essential medium